Compounds > sf 2197
Page last updated: 2024-12-07

sf 2197

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

matlystatin B: structure given in first source; from Actinomadura atramentaria [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132321
MeSH IDM0211234

Synonyms (9)

Synonym
140923-32-6
1(2h)-pyridazinebutanamide, tetrahydro-n-hydroxy-6-(((2-methyl-1-(1-oxopropyl)butyl)amino)carbonyl)-gamma-oxo-beta-pentyl-
tetrahydro-n-hydroxy-6-(((2-methyl-1-(1-oxopropyl)butyl)amino)carbonyl)-gamma-oxo-beta-pentyl-1(2h)-pyridazinebutanamide
sf 2197
sf-2197
matlystatin b
2-[2-(2-amino-2-oxoethyl)heptanoyl]-1-hydroxy-n-(3-methyl-5-oxoheptan-4-yl)diazinane-3-carboxamide
DTXSID50930949
1-hydroxy-2-[2-(2-hydroxy-2-iminoethyl)heptanoyl]-n-(3-methyl-5-oxoheptan-4-yl)-1,2-diazinane-3-carboximidic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
ornithine
Ornithine: An amino acid produced in the urea cycle by the splitting off of urea from arginine.. ornithine : An alpha-amino acid that is pentanoic acid bearing two amino substituents at positions 2 and 5.		2.1510non-proteinogenic L-alpha-amino acid;
ornithine		algal metabolite;
hepatoprotective agent;
mouse metabolite
acetylcysteine
N-acetyl-L-cysteine : An N-acetyl-L-amino acid that is the N-acetylated derivative of the natural amino acid L-cysteine.		2.9140acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid		antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine
[no description available]		1.9810
actinonin
actinonin: natural hydroxamic acid, pseudopeptide antibiotic isolated from Streptomyces species; structure		2.1510
ConditionIndicatedRelationship StrengthStudiesTrials
Fibrosarcoma
A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)		02.3920